Medication Nonadherence in Systemic Lupus Erythematosus: A Systematic Review

Arthritis Care and Research

Volumn 69, Issue 11, 2017, Pages 1706-1713

  Mehat, Pavandeep ^a   Atiquzzaman, Mohammad ^a   Esdaile, John M ^a   AviÑa Zubieta, Antonio ^a   De Vera, Mary A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLATE MOFETIL; PREDNISONE;

ARTICLE; CLINICAL OUTCOME; DEPRESSION; EDUCATION; ELECTRONIC MONITORING DEVICE; EVIDENCE BASED MEDICINE; FOLLOW UP; HUMAN; MEDICAL RECORD; PATIENT COMPLIANCE; PATIENT INFORMATION; PHARMACY; POLYPHARMACY; RURAL AREA; SAMPLE SIZE; SELF REPORT; STUDY DESIGN; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEDICATION COMPLIANCE; PSYCHOLOGY;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEDICATION ADHERENCE; SELF REPORT;

EID: 85026868080     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.23191     Document Type: Article

References (32)

1. Firestein GS, Budd RC, Gabriel SE, McInnes IB, O'Dell JR. Kelley's textbook of rheumatology: expert consult premium edition. 9th ed. Philadelphia (PA): Saunders; 2012.
2. Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD. Manifestations of systemic lupus erythematosus. Maedica (Buchar) 2011;6:330–6.
3. Klippel JH, Stone JH, White PH. Primer on the rheumatic diseases. New York: Springer Science & Business Media; 2008.
4. Feldman CH, Hiraki LT, Liu J, Fischer MA, Solomon DH, Alarcón GS, et al. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000–2004. Arthritis Rheum 2013;65:753–63.
5. Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, et al. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 2012;71:1771–82.
6. Aviña-Zubieta JA, Esdaile JM. Antimalarial medications. In: Wallace D, Hahn BH, editors. Dubois' lupus erythematosus and related syndromes. 8th ed. Philadelphia (PA): Elsevier Saunders; 2012. p. 601–8.
7. Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006;54:2550–7.
8. Harrold LR, Andrade SE. Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature. Semin Arthritis Rheum 2009;38:396–402.
9. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009;119:3028–35.
10. Sabaté E, World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
11. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007;147:573–7.
12. Mosley-Williams A, Lumley MA, Gillis M, Leisen J, Guice D. Barriers to treatment adherence among African American and white women with systemic lupus erythematosus. Arthritis Rheum 2002;47:630–8.
13. Garcia-Gonzalez A, Richardson M, Garcia Popa-Lisseanu M, Cox V, Kallen MA, Janssen N, et al. Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 2008;27:883–9.
14. Daleboudt GM, Broadbent E, McQueen F, Kaptein AA. Intentional and unintentional treatment nonadherence in patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2011;63:342–50.
15. Oliveira-Santos M, Verani JF, Klumb EM, Albuquerque EM. Evaluation of adherence to drug treatment in patients with systemic lupus erythematosus in Brazil. Lupus 2011;20:320–9.
16. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67–74.
17. Abdul-Sattar AB, Abou El Magd SA. Determinants of medication non-adherence in Egyptian patients with systemic lupus erythematosus: Sharkia Governorate. Rheumatol Int 2014;35:1045–51.
18. Marengo MF, Waimann CA, de Achaval S, Zhang H, Garcia-Gonzalez A, Richardson MN, et al. Measuring therapeutic adherence in systemic lupus erythematosus with electronic monitoring. Lupus 2012;21:1158–65.
19. Morand EF, McCloud PI, Littlejohn GO. Continuation of long term treatment with hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 1992;51:1318–21.
20. Wang C, Fortin PR, Li Y, Panaritis T, Gans M, Esdaile JM. Discontinuation of antimalarial drugs in systemic lupus erythematosus. J Rheumatol 1999;26:808–15.
21. Tsang-A-Sjoe MW, Bultink IE, Voskuyl AE. Long-term evaluation of antimalarials in a Dutch SLE cohort: intolerance and other reasons for non-use. Clin Exp Rheumatol 2014;32:95–100.
22. Koneru S, Kocharla L, Higgins GC, Ware A, Passo MH, Farhey YD, et al. Adherence to medications in systemic lupus erythematosus. J Clin Rheumatol 2008;14:195–201.
23. Koneru S, Shishov M, Ware A, Farhey Y, Mongey AB, Graham TB, et al. Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting. Arthritis Rheum 2007;57:1000–6.
24. Kimmel S. Textbook of pharmacoepidemiology. Hoboken (NJ): John Wiley & Sons; 2006.
25. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997;50:105–16.
26. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487–97.
27. Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006;40:1280–8.
28. Peterson AM, Nau DP, Cramer JA, Benner J, Gwadry-Sridhar F, Nichol M. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007;10:3–12.
29. Feldman CH, Yazdany J, Guan H, Solomon DH, Costenbader KH. Medication nonadherence is associated with increased subsequent acute care utilization among Medicaid beneficiaries with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2015;67:1712–21.
30. Rojas-Serrano J, Cardiel MH. Lupus patients in an emergency unit: causes of consultation, hospitalization and outcome. A cohort study. Lupus 2000;9:601–6.
31. Julian LJ, Yelin E, Yazdany J, Panopalis P, Trupin L, Criswell LA, et al. Depression, medication adherence, and service utilization in systemic lupus erythematosus. Arthritis Rheum 2009;61:240–6.
32. Costedoat-Chalumeau N, Pouchot J, Guettrot-Imbert G, Le Guern V, Leroux G, Marra D, et al. Adherence to treatment in systemic lupus erythematosus patients. Best Pract Res Clin Rheumatol 2013;27:329–40.